相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。ALPS, FAS, and beyond: from inborn errors of immunity to acquired immunodeficiencies
Filippo Consonni et al.
ANNALS OF HEMATOLOGY (2022)
Everolimus-Induced Pneumonitis in Patients with Neuroendocrine Neoplasms: Real-World Study on Risk Factors and Outcomes
Rodrigo G. Taboada et al.
ONCOLOGIST (2022)
Effect of Rapamycin on MOG-Reactive Immune Cells and Lipopolysaccharide-Activated Microglia: An In Vitro Approach for Screening New Therapies for Multiple Sclerosis
Patricia Aparecida Borim et al.
JOURNAL OF INTERFERON AND CYTOKINE RESEARCH (2022)
Sirolimus is effective for refractory/relapsed/intolerant acquired pure red cell aplasia: results of a prospective single-institutional trial
Yuzhou Huang et al.
LEUKEMIA (2022)
Advances in Immunosuppressive Agents Based on Signal Pathway
Zhiqing Xu et al.
FRONTIERS IN PHARMACOLOGY (2022)
Everolimus ameliorates Helicobacter pylori infection-induced inflammation in gastric epithelial cells
Jinglei Liu et al.
BIOENGINEERED (2022)
Sirolimus Monotherapy for Thrombocytopenia in Primary Antiphospholipid Syndrome: A Pilot Study From a Tertiary Referral Center
Wenhui Xie et al.
FRONTIERS IN IMMUNOLOGY (2022)
Recent advances in treatments of adult immune thrombocytopenia
Dae Sik Kim
BLOOD RESEARCH (2022)
Current therapeutic strategies and perspectives in refractory ITP: What have we learned recently?
Yue Lv et al.
FRONTIERS IN IMMUNOLOGY (2022)
Small biomarkers with massive impacts: PI3K/AKT/mTOR signalling and microRNA crosstalk regulate nasopharyngeal carcinoma
Hai-Long Li et al.
BIOMARKER RESEARCH (2022)
Clinical characteristics in immune thrombocytopenia patients after COVID-19 vaccination
Yimei Feng et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2022)
A Review on Secondary Immune Thrombocytopenia in Malaysia
Muhamad Aidil Zahidin et al.
HEALTHCARE (2022)
Sirolimus for patients with connective tissue disease-related refractory thrombocytopenia: a single-arm, open-label clinical trial
Chanyuan Wu et al.
RHEUMATOLOGY (2021)
The Role of mTOR Inhibitors in Hematologic Disease: From Bench to Bedside
Yimei Feng et al.
FRONTIERS IN ONCOLOGY (2021)
Rapamycin alleviates renal damage in mice with systemic lupus erythematosus through improving immune response and function
Xinghui Song et al.
BIOMEDICINE & PHARMACOTHERAPY (2021)
Platelet autoantibody specificity and response to rhTPO treatment in patients with primary immune thrombocytopenia
Yafei Yu et al.
BRITISH JOURNAL OF HAEMATOLOGY (2021)
Case Report: Sirolimus Alleviates Persistent Cytopenia After CD19 CAR-T-Cell Therapy
Limin Xing et al.
FRONTIERS IN ONCOLOGY (2021)
Intranodal Sirolimus Induces Regulatory T Cells in Human Hepatic Lymph Nodes via Interleukin 10 Signaling
Justin H. Nguyen et al.
LIVER TRANSPLANTATION (2021)
Low-dose rapamycin does not impair vascular integrity and tubular regeneration after kidney transplantation in rats
Uwe Hoff et al.
SCIENTIFIC REPORTS (2021)
The Addition of Sirolimus to GVHD Prophylaxis After Allogeneic Hematopoietic Stem Cell Transplantation: A Meta-Analysis of Efficacy and Safety
Xiaoli Chen et al.
FRONTIERS IN ONCOLOGY (2021)
Abnormalities of Bone Marrow B Cells and Plasma Cells in Primary Immune Thrombocytopenia
Tianshu Yu et al.
Blood Advances (2021)
Development and validation of a nomogram for steroid-resistance prediction in immune thrombocytopenia patients
Jieni Yu et al.
HEMATOLOGY (2021)
Sirolimus is effective in autoimmune lymphoproliferative syndrome-type III: A pedigree case report with homozygous variation PRKCD
Hao Gu et al.
INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY (2021)
Identifying and treating refractory ITP: difficulty in diagnosis and role of combination treatment
Oriana Miltiadous et al.
BLOOD (2020)
The advantage of Sirolimus in amplifying regulatory B cells and regulatory T cells in liver transplant patients
Jiyong Song et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2020)
Rapamycin inhibits B-cell activating factor (BAFF)-stimulated cell proliferation and survival by suppressing Ca2+-CaMKII-dependent PTEN/Akt-Erk1/2 signaling pathway in normal and neoplastic B-lymphoid cells
Qingyu Zeng et al.
CELL CALCIUM (2020)
Sirolimus is effective for primary relapsed/refractory autoimmune cytopenia: a multicenter study
Hongmin Li et al.
EXPERIMENTAL HEMATOLOGY (2020)
Short-Term Rapamycin Preconditioning Diminishes Therapeutic Efficacy of Human Adipose-Derived Stem Cells in a Murine Model of Multiple Sclerosis
Rachel M. Wise et al.
CELLS (2020)
Sirolimus versus cyclosporine for the treatment of pediatric chronic immune thrombocytopenia: A randomized blinded trial
Morteza Mousavi-Hasanzadeh et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2020)
Sirolimus as Rescue Therapy for Refractory/Relapsed Immune Thrombocytopenia: Results of a Single-Center, Prospective, Single-Arm Study
Yimei Feng et al.
FRONTIERS IN MEDICINE (2020)
Megakaryocytic dysfunction in immune thrombocytopenia is linked to autophagy
Rui-jie Sun et al.
CANCER CELL INTERNATIONAL (2019)
Targeting mTOR for cancer therapy
Hui Hua et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2019)
Enhancing autophagy protects platelets in immune thrombocytopenia patients
Chun-Yan Wang et al.
ANNALS OF TRANSLATIONAL MEDICINE (2019)
Effect of Sirolimus Exposure on the Need for Preemptive Antiviral Therapy for Cytomeglovirus Infection after Allogeneic Hematopoietic Stem Cell Transplantation
Beatriz Guglieri-Lopez et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2019)
Inhibition of T Helper Cell Differentiation by Tacrolimus or Sirolimus Results in Reduced B-Cell Activation: Effects on T Follicular Helper Cells
Rens Kraaijeveld et al.
TRANSPLANTATION PROCEEDINGS (2019)
Updated international consensus report on the investigation and management of primary immune thrombocytopenia
Drew Provan et al.
BLOOD ADVANCES (2019)
Rapamycin attenuates BAFF-extended proliferation and survival via disruption of mTORC1/2 signaling in normal and neoplastic B-lymphoid cells
Qingyu Zeng et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2018)
Clinical impact and management of fluconazole discontinuation on sirolimus levels in bone marrow transplant patients
Edith Nwaroh et al.
JOURNAL OF ONCOLOGY PHARMACY PRACTICE (2018)
Synergistic defects of novo FAS and homozygous UNC13D leading to autoimmune lymphoproliferative syndrome-like disease: A 10-year-old Chinese boy case report
Hao Gu et al.
GENE (2018)
Chinese guidelines for treatment of adult primary immune thrombocytopenia
Xin-guang Liu et al.
INTERNATIONAL JOURNAL OF HEMATOLOGY (2018)
Sirolimus in patients with clinically active systemic lupus erythematosus resistant to, or intolerant of, conventional medications: a single-arm, open-label, phase 1/2 trial
Zhi-Wei Lai et al.
LANCET (2018)
Low-dose sirolimus in two cousins with autoimmune lymphoproliferative syndrome-associated infection
Agostino Nocerino et al.
PEDIATRICS INTERNATIONAL (2018)
Recent advances in analytical methods for the therapeutic drug monitoring of immunosuppressive drugs
Yu Zhang et al.
DRUG TESTING AND ANALYSIS (2018)
mTORC1 and mTORC2 as regulators of cell metabolism in immunity
Monika Linke et al.
FEBS LETTERS (2017)
Sirolimus as an Effective Agent in the Treatment of Immune Thrombocytopenia (ITP) and Evans Syndrome (ES): A Single Institution's Experience
Sylwia Jasinski et al.
JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY (2017)
Autoimmune hepatitis: standard treatment and systematic review of alternative treatments
Benedetta Terziroli Beretta-Piccoli et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2017)
Pathogenesis and Therapeutic Mechanisms in Immune Thrombocytopenia (ITP)
Anne Zufferey et al.
JOURNAL OF CLINICAL MEDICINE (2017)
Rapamycin Eye Drops Suppress Lacrimal Gland Inflammation In a Murine Model of Sjogren's Syndrome
Mihir Shah et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2017)
Circulating myeloid-derived suppressor cells predict disease activity and treatment response in patients with immune thrombocytopenia
J. Zhou et al.
BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH (2017)
Safety and efficacy of long-term treatment of chronic/persistent ITP with eltrombopag: final results of the EXTEND study
Raymond S. M. Wong et al.
BLOOD (2017)
Phosphoinositide 3-kinase (PI3K) pathway inhibitors in solid tumors: From laboratory to patients
Filip Janku
CANCER TREATMENT REVIEWS (2017)
The cytokine polymorphisms affecting Th1/Th2 increase the susceptibility to, and severity of, chronic ITP
Noriyuki Takahashi et al.
BMC IMMUNOLOGY (2017)
Sirolimus is effective in relapsed/refractory autoimmune cytopenias: results of a prospective multi-institutional trial
Karen L. Bride et al.
BLOOD (2016)
How I manage Evans Syndrome and AIHA cases in children
Maurizio Miano
BRITISH JOURNAL OF HAEMATOLOGY (2016)
mTOR inhibitors effects on regulatory T cells and on dendritic cells
Giovanni Stallone et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2016)
Effects of molecularly targeted therapies on murine thymus: highly selective mTOR inhibitors induce reversible thymic involution
Suleiman Al-Hammadi et al.
EXPERIMENTAL HEMATOLOGY & ONCOLOGY (2016)
Rapamycin inhibits BAFF-stimulated cell proliferation and survival by suppressing mTOR-mediated PP2A-Erk1/2 signaling pathway in normal and neoplastic B-lymphoid cells
Qingyu Zeng et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2015)
IL-10/Janus kinase/signal transducer and activator of transcription 3 signaling dysregulates Bim expression in autoimmune lymphoproliferative syndrome
Omar Niss et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2015)
Role of autophagy and mTOR signaling in neural differentiation of bone marrow mesenchymal stem cells
Yanfei Li et al.
CELL BIOLOGY INTERNATIONAL (2014)
Bone marrow fibrosis in 66 patients with immune thrombocytopenia treated with thrombopoietin-receptor agonists: a single-center, long-term follow-up
Waleed Ghanima et al.
HAEMATOLOGICA (2014)
Splenectomy and the incidence of venous thromboembolism and sepsis in patients with immune thrombocytopenia
Soames Boyle et al.
BLOOD (2013)
Effects of Rapamycin Combined with Low Dose Prednisone in Patients with Chronic Immune Thrombocytopenia
Jiaming Li et al.
CLINICAL & DEVELOPMENTAL IMMUNOLOGY (2013)
CD19+CD24hiCD38hi B Cells Maintain Regulatory T Cells While Limiting TH1 and TH17 Differentiation
Fabian Flores-Borja et al.
SCIENCE TRANSLATIONAL MEDICINE (2013)
mTOR and GSK-3 shape the CD4+ T-cell stimulatory and differentiation capacity of myeloid DCs after exposure to LPS
Heth R. Turnquist et al.
BLOOD (2010)
Rituximab-Associated Infections
Juan C. Gea-Banacloche
SEMINARS IN HEMATOLOGY (2010)
Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group
Francesco Rodeghiero et al.
BLOOD (2009)
The effects of BAFF and BAFF-R-Fc fusion protein in immune thrombocytopenia
Xiao-juan Zhu et al.
BLOOD (2009)
Distinct roles of the mTOR components Rictor and Raptor in MO7e megakaryocytic cells
Gwenny M. Fuhler et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2009)
Rapamycin-treated mature dendritic cells have a unique cytokine secretion profile and impaired allostimulatory capacity
Guo-Ying Wang et al.
TRANSPLANT INTERNATIONAL (2009)
Target of rapamycin inhibitors (Sirolimus and Everolimus) for primary immunosuppression of kidney transplant recipients: A systematic review and meta-analysis of randomized trials
Angela C. Webster et al.
TRANSPLANTATION (2006)
分享论文
